BFNH — BioForce Nanosciences Holdings Share Price
0.000.00%
Last trade - 00:00- $53.57m
- $53.57m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioForce Nanosciences Holdings, Inc. is a provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company markets its products through social media and telemarketing. The Company seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Company’s Eclipse product lines. The Company private labels the powder through a manufacturer located in Virginia. The Company caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The Company also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Company’s wholly owned subsidiary is Element Global, Inc.
Directors
- Merle Ferguson CHM (74)
- Sasha Shapiro PRE
- Steven Gagnon CCE
- John La Violette CCE
- Richard Kaiser CFO (56)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 10th, 1999
- Public Since
- October 11th, 2005
- No. of Shareholders
- 236
- No. of Employees
- 3
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 29,271,755
- Address
- 2020 General Booth Blvd Ste 230, VIRGINIA BEACH, 23454
- Web
- https://bioforceeclipse.com/
- Phone
- +1 7573066090
- Auditors
- BF Borgers CPA PC
Upcoming Events for BFNH
Q2 2024 BioForce Nanosciences Holdings Inc Earnings Release
Similar to BFNH
Arion
Pink Sheets on Nasdaq
Avolta AG
Pink Sheets on Nasdaq
bebe stores
Pink Sheets on Nasdaq
Better for You Wellness
Pink Sheets on Nasdaq
Cambell International Holding
Pink Sheets on Nasdaq
FAQ
What is the BioForce Nanosciences Holdings share price?
As of Today at 19:04 UTC, shares in BioForce Nanosciences Holdings are trading at $1.83. This share price information is delayed by 15 minutes.
How has the BioForce Nanosciences Holdings share price performed this year?
Shares in BioForce Nanosciences Holdings last closed at $1.83 and the price had moved by +79.41% over the past 365 days. In terms of relative price strength the BioForce Nanosciences Holdings share price has outperformed the S&P500 Index by +54.23% over the past year.
What are the analyst and broker recommendations for BioForce Nanosciences Holdings?
There is no consensus recommendation for this security.
What is the BioForce Nanosciences Holdings dividend yield?
BioForce Nanosciences Holdings does not currently pay a dividend.
Does BioForce Nanosciences Holdings pay a dividend?
BioForce Nanosciences Holdings does not currently pay a dividend.
When does BioForce Nanosciences Holdings next pay dividends?
BioForce Nanosciences Holdings does not currently pay a dividend.
How do I buy BioForce Nanosciences Holdings shares?
To buy shares in BioForce Nanosciences Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BioForce Nanosciences Holdings?
As of the previous close price of $1.83, shares in BioForce Nanosciences Holdings had a market capitalisation of $53.57m.
Where are BioForce Nanosciences Holdings shares listed?
Here are the trading details for BioForce Nanosciences Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BFNH
What kind of share is BioForce Nanosciences Holdings?
Based on an overall assessment of its quality, value and momentum BioForce Nanosciences Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BioForce Nanosciences Holdings share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the BioForce Nanosciences Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioForce Nanosciences Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -32.5%.
As of the last closing price of $1.83, shares in BioForce Nanosciences Holdings were trading -4.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BioForce Nanosciences Holdings PE Ratio?
The BioForce Nanosciences Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BioForce Nanosciences Holdings?
BioForce Nanosciences Holdings' management team is headed by:
- Merle Ferguson - CHM
- Sasha Shapiro - PRE
- Steven Gagnon - CCE
- John La Violette - CCE
- Richard Kaiser - CFO